• Insurance Quotes
  • Contact
  • Privacy Policy
  • Terms & Conditions
Monday, June 8, 2026
Insure Monkey
844-226-8876
  • Home
  • Low Cost Health Insurance
  • News
    • Health Insurance
    • Insurance for Business
    • Health Care
    • Medicare
    • Casualty Insurance
    • Insurance Education
    • Life Insurance
  • Contact
  • Home
  • Low Cost Health Insurance
  • News
    • Health Insurance
    • Insurance for Business
    • Health Care
    • Medicare
    • Casualty Insurance
    • Insurance Education
    • Life Insurance
  • Contact
No Result
View All Result
Morning News
No Result
View All Result
Home Medicare

Seeking Medicare Coverage for Weight Loss Drugs, Pharma Giant Courts Black Influencers

August 8, 2023
in Medicare
0
Seeking Medicare Coverage for Weight Loss Drugs, Pharma Giant Courts Black Influencers
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

READ ALSO

That Discount at the Pharmacy Counter May Pack Hidden Costs

HHS’ Healthy Food Agenda Puts Hospitals on Notice About Patients’ Meals

Pharmaceutical large Novo Nordisk has turned to influential Black Individuals in pursuit of what could be a profitable victory: having Medicare cowl a brand new class of weight reduction medicine, together with the corporate’s extremely sought Wegovy, which may value sufferers greater than $1,000 a month.

Throughout a convention of the Congressional Black Caucus Basis final fall — a jampacked gathering that includes outstanding Black lawmakers and President Joe Biden — Novo Nordisk sponsored a panel dialogue on weight problems for which it chosen the moderator and panelists, firm spokesperson Nicole Ferreira stated. The muse is a nonprofit affiliated with the Congressional Black Caucus, a strong group of lawmakers on Capitol Hill.

Former CNN political commentator Roland Martin moderated. Black well being consultants who help Medicare protection of medicine used to deal with weight problems served on the panel. They included Fatima Cody Stanford, an affiliate professor of drugs at Harvard Medical Faculty. Stanford is a specialist in weight problems who has acquired consulting charges from Novo Nordisk.

Throughout the panel dialogue, Stanford advised the viewers that weight problems “is an actual illness that individuals battle with,” she recounted in an interview with KFF Well being Information. “We’ve denied folks take care of weight problems once we haven’t for different power ailments.”

Novo Nordisk, the main maker of so-called weight problems medicine, adopted up on the September panel by sponsoring a streaming present in March hosted by Martin, throughout which visitors advocated for Medicare to cowl medicine for weight reduction. Ferreira stated the corporate prompt consultants for the phase, however she didn’t title them.

These actions are a part of a broader Novo Nordisk marketing campaign to shift the general public narrative about weight problems. They open a brand new window on drugmakers’ efforts to affect customers and public coverage.

See also  While Inflation Takes a Toll on Seniors, Billions of Dollars in Benefits Go Unused

Novo Nordisk is attempting to reverse a 20-year-old ban on protection of medicine used for weight reduction below Medicare, the federal medical insurance program primarily for folks 65 and older. Congress excluded such drugs when it established Medicare’s Half D prescription drug profit in 2003. The ban successfully deprives drugmakers of thousands and thousands of potential clients.

Increasing the Affected person Pool

Medicare protection would put weight problems medicine inside attain of many individuals who couldn’t in any other case afford them. It may have a multiplier impact as a result of non-public insurers typically observe Medicare’s lead.

It could be a monetary boon to Novo Nordisk and different drugmakers, together with Eli Lilly, which is in search of FDA approval for a weight reduction drug.

Including to the price, and the potential upside for the business: To maintain weight off, sufferers could must take the medicine indefinitely.

Wegovy’s record value is about $1,350 for roughly a month’s provide. Eli Lilly’s Mounjaro, a drug for folks with Sort 2 diabetes that medical doctors prescribe off-label for weight problems, is priced at about $1,023 for roughly a month’s provide.

Wegovy is FDA-approved for weight reduction in adults who’ve a physique mass index of 30 or higher — the definition of grownup weight problems, in line with the Facilities for Illness Management and Prevention — or a BMI of at the very least 27 plus at the very least one weight-related medical situation, similar to hypertension. It’s additionally permitted for sufferers as younger as 12 who’re deemed overweight.

In an announcement, Novo Nordisk spokesperson Allison Schneider stated, “We advocate for sufferers and insurance policies that help entry to all weight problems remedies, together with protection for anti-obesity drugs in Medicare Half D.”

See also  Medicare Advantage Is Popular, but Some Beneficiaries Feel Buyer’s Remorse

The corporate helps the Deal with and Scale back Weight problems Act, laws launched in 2013 that might overturn the Medicare protection ban. In July, a bipartisan group of lawmakers within the Home and Senate reintroduced the invoice — one thing lawmakers have finished repeatedly over the last decade.

Drug corporations have lengthy used a wide range of methods to advance company pursuits, similar to funding so-called affected person advocacy teams centered on particular ailments and airing direct-to-consumer advertisements that spur sufferers to ask their medical doctors about brand-name medicine.

Novo Nordisk is the largest company donor to the Weight problems Motion Coalition, which says its mission is “to raise and empower these affected by weight problems.”

Novo Nordisk contributes greater than $500,000 yearly to the group, in line with its web site. The group’s legislative aims embrace reversing Medicare’s protection ban on weight reduction medicine.

The Weight problems Motion Coalition “just isn’t influenced in any manner by our huge array of supporters,” stated Kendall Griffey, a spokesperson for the group.

Novo Nordisk has marketed Wegovy, which the FDA permitted for weight reduction in 2021, and Ozempic, which is permitted for diabetes and prescribed off-label to deal with weight problems.

Like many massive companies, Novo Nordisk has contributed 1000’s of {dollars} yearly to nonprofits tied to totally different teams of lawmakers whereas in search of help in Congress for its causes.

In 2021, Novo Nordisk gave between $100,000 and $399,999 to the Congressional Black Caucus Basis and between $25,000 and $49,999 to the Asian Pacific American Institute for Congressional Research, in line with every nonprofit’s annual report.

See also  How to easily make your right Medicare decision • IM

The latter nonprofit, often known as APAICS, is affiliated with the Congressional Asian Pacific American Caucus. APAICS lists Novo Nordisk as a associate on webpages for occasions in March and Could the place panel discussions touched on the therapy of weight problems.

The Congressional Hispanic Caucus Institute additionally lists Novo Nordisk as a donor however doesn’t state how a lot the corporate contributed.

The Congressional Black Caucus, Congressional Hispanic Caucus, and Congressional Asian Pacific American Caucus again a invoice on well being disparities that in 2022 was revised to scrap Medicare’s prohibition on overlaying prescriptions for weight reduction.

The Congressional Black Caucus Basis, the Congressional Hispanic Caucus Institute, and the Asian Pacific American Institute for Congressional Research didn’t reply to questions for this text. Novo Nordisk declined to say how a lot it contributed to the Congressional Black Caucus Basis’s 2022 legislative convention and whether or not it sponsored the panel to affect Congressional Black Caucus members’ positions; it equally declined to specify its most up-to-date annual contribution to the Congressional Hispanic Caucus Institute and its monetary contributions for numerous APAICS occasions this 12 months. “We help a number of organizations to assist educate on and spotlight points vital to their communities,” firm spokesperson Natalia Salomao stated of Novo Nordisk’s relationship with the nonprofits.

Excessive-Profile Promoters

Martin’s streaming day by day information present in March featured an hourlong phase “powered by Novo Nordisk” on weight problems amongst Black Individuals. Ferreira, of Novo Nordisk, stated Martin and Novo Nordisk “agreed {that a} phase on his present was an excellent alternative to succeed in his viewers to assist additional inform them about weight problems as a power illness and the significance of excellent vitamin and well being care.”

Martin didn’t reply to requests for remark. Throughout the episode, he cited Novo Nordisk’s position. “I definitely need to thank them for partnering with us,” he stated.

Company pushed for Medicare to cowl sufferers’ anti-obesity prescriptions, with an eye fixed towards what protection may imply for seniors and different adults. The federal authorities is “imagined to be main the best way on this,” Nelson Dunlap, vp of public coverage and exterior affairs for Meharry Medical Faculty, a traditionally Black establishment, stated throughout the phase.

“Industrial insurances are inclined to observe what Medicare does,” Tiffani Bell Washington, a psychiatrist specializing in weight problems medication, stated on the present. Weight problems is “a well being problem. So it actually does should be lined, and if Medicare covers it, normally different folks observe.”

Dunlap declined to remark for this text, and Bell Washington didn’t reply questions despatched by electronic mail.

Novo Nordisk enlisted Black music and leisure stars Queen Latifah and Yvette Nicole Brown to be paid spokespeople for an academic marketing campaign that started in 2021 speaking that weight problems is a power illness and must be handled like different illnesses. Each celebrities have overtly talked about dwelling with weight problems.

Stanford, one of many individuals within the September panel, in 2022 acquired $23,188 from Novo Nordisk, practically double what she acquired from the corporate in 2021, federal data present. The 2022 funds embrace consulting charges and bills for meals and journey.

“I wouldn’t need somebody that has no information informing them on how this really works in actual life,” Stanford stated, explaining her relationship with the businesses. “The folks they study from are folks like me, the folks that really do that work on the bottom every single day with sufferers.”

One other panelist was Eric Griggs, an assistant vp at Entry Well being Louisiana, a community of federally certified well being facilities. In an interview, Griggs stated Medicare protection of weight problems medicine “would assist the answer. For those who may also help one group, you may assist all of them.”

In accordance with the Facilities for Illness Management and Prevention, based mostly on BMI, 50% of non-Hispanic Black adults within the U.S. are labeled as overweight, the very best charge for any race or ethnicity.

Nevertheless, the BMI measurement has more and more come below criticism as flawed. In June, the American Medical Affiliation stated it “doesn’t account for variations throughout race/ethnic teams, sexes, genders, and age-span.”

Since 2014, Novo Nordisk has spent greater than $30 million lobbying members of Congress and different federal officers, in line with a KFF Well being Information evaluate of lobbying disclosures. A constant topic is the Deal with and Scale back Weight problems Act.

“We now have huge well being care challenges that movement from weight problems,” stated Sen. Tom Carper (D-Del.), a lead sponsor of that laws. He argued that spending cash on weight reduction medicine would cut back spending on power ailments that drive up the federal authorities’s well being care tab.

Carper is a longtime recipient of marketing campaign money from drug corporations, together with makers of weight reduction medicine. Nevertheless, some researchers specific warning about lifting Medicare’s protection ban. For seniors, the unwanted side effects of such medicine may very well be extra harmful, in line with a paper by students  at Vanderbilt College and the College of Chicago.

Uncomfortable side effects for Wegovy and Ozempic could embrace kidney issues, gallbladder illness, irritation of the pancreas, and thyroid most cancers, in line with the product labels. Suicidal ideas are listed as a doubtlessly critical aspect impact of Wegovy, its label says.

The Vanderbilt and Chicago researchers discovered that, even with modest uptake of the drugs, annual Medicare Half D bills may enhance by $13.6 billion. That might go away policymakers “within the place of creating broad cuts to different forms of care,” stated Khrysta Baig, one of many paper’s authors.

However individuals who need Medicare and different insurance coverage applications to cowl the medicine emphasize potential benefits.

Protection would save “the lives that we’re shedding at early ages, particularly within the Black group,” Bell Washington stated on Martin’s present in March, earlier than calling on viewers to take motion. “It’s essential to write to your legislators, ensure you’re selecting people who find themselves in help of well being take care of all,” she stated.

Associated Matters

Contact Us

Submit a Story Tip

Tags: BlackCourtsCoverageDrugsGiantInfluencersLossMedicarePharmaSeekingWeight

Related Posts

That Discount at the Pharmacy Counter May Pack Hidden Costs
Medicare

That Discount at the Pharmacy Counter May Pack Hidden Costs

May 7, 2026
Florida Delays Children’s Health Insurance Expansion as Uninsured Rate Rises
Medicare

HHS’ Healthy Food Agenda Puts Hospitals on Notice About Patients’ Meals

May 4, 2026
Medigap Premiums Leap, and Consumers Have Few Alternatives
Medicare

Medigap Premiums Leap, and Consumers Have Few Alternatives

April 30, 2026
The Help That Many Older Americans Need Most
Medicare

The Help That Many Older Americans Need Most

April 29, 2026
Real Estate Investors Profit From Long-Term Care While Residents Languish
Medicare

Real Estate Investors Profit From Long-Term Care While Residents Languish

April 21, 2026
Watch: As AI Makes More Health Coverage Decisions, the Risks to Patients Grow
Medicare

Watch: As AI Makes More Health Coverage Decisions, the Risks to Patients Grow

April 10, 2026
Next Post
Don’t Defend Planned Parenthood’s ‘Gender-Affirming Care.’ Defund It.

Don't Defend Planned Parenthood’s 'Gender-Affirming Care.' Defund It.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

POPULAR ARTICLES

How price shopping for health care can save you money (and how to do it)

How price shopping for health care can save you money (and how to do it)

August 1, 2022
Watch: Explaining the Nitty-Gritty of Medicare Drug Price Negotiations — And Patients’ Potential Savings

Watch: Explaining the Nitty-Gritty of Medicare Drug Price Negotiations — And Patients’ Potential Savings

August 1, 2022
Police Life Insurance [The Top 7 Job Risks that May Affect Your Rate!]

Police Life Insurance [The Top 7 Job Risks that May Affect Your Rate!]

March 31, 2023
Hospices Have Become Big Business for Private Equity Firms, Raising Concerns About End-of-Life Care

Hospices Have Become Big Business for Private Equity Firms, Raising Concerns About End-of-Life Care

August 1, 2022
Get Inflation Beating Retirement Income with Whole Life Insurance • The Insurance Pro Blog

Get Inflation Beating Retirement Income with Whole Life Insurance • The Insurance Pro Blog

October 6, 2022

EDITOR'S PICK

These 3 Policy Moves Are Likely To Change Health Care for Older People

Estas medidas podrían cambiar la calidad de la atención médica de las personas mayores

January 26, 2026
Medicare Expands the Roster of Available Mental Health Professionals

Medicare Expands the Roster of Available Mental Health Professionals

November 3, 2023
FDA Considers Over-the-Counter Birth Control. Here’s Why It Matters.

FDA Considers Over-the-Counter Birth Control. Here’s Why It Matters.

August 2, 2022
Retiree Health Plans for Mom-and-Pop Businesses

Retiree Health Plans for Mom-and-Pop Businesses

January 25, 2025

About

Insure Monkey is a free service to assist users in getting insurance quotes from insurance providers. Insure Monkey is not affiliated with any state or government agency. Insure Monkey is not an insurance agency or broker, nor an insurance referral service. Insure Monkey does not endorse or recommend any participating Third-Party Insurance Providers that pay to participate in this advertising.

Categories

  • Auto Insurance
  • Casualty Insurance
  • Health Care
  • Health Insurance
  • Insurance Education
  • Insurance for Business
  • Life Insurance
  • Medicare
  • Uncategorized

Recent Posts

  • Does Infinite Banking Work? Yes, For Borrowers Only
  • Whole Life as Portfolio Insurance: A Windfall Case Study
  • Louisiana’s Reporting Law Chills Immigrant Medicaid Applications

Newsletter

  • Insurance Quotes
  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2024 Insure Monkey - All rights reserved.

No Result
View All Result
  • Home
  • Low Cost Health Insurance
  • News
    • Health Insurance
    • Insurance for Business
    • Health Care
    • Medicare
    • Casualty Insurance
    • Insurance Education
    • Life Insurance
  • Contact

© 2024 Insure Monkey - All rights reserved.